跳转至内容
Merck
CN

330726P

Avanti

C13-dihydroceramide-d7(d18:0-d7/13:0)

Avanti Research - A Croda Brand

别名:

N-tridecanoyl-D-erythro-sphinganine-d7

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C31H56D7NO3
化学文摘社编号:
分子量:
504.88
MDL number:
NACRES:
NA.12
UNSPSC Code:
12352211
Assay:
99% (TLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


assay

99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (330726P-1MG)

manufacturer/tradename

Avanti Research - A Croda Brand

shipped in

dry ice

storage temp.

−20°C

General description

C13-dihydroceramide-d7 (d18:0-d7/13:0) is a deuterated derivative of C13-dihydroceramide.

Biochem/physiol Actions

Dihydroceramide is involved in the regulation of autophagy, hypoxia and cell proliferation.

Packaging

5 mL Amber Glass Screw Cap Vial

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库